Mobile Medication Adherence Platform for Buprenorphine-Naloxone During Treatment of Opioid Use Disorder: Phase I Study
NCT04656899
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
41
Enrollment
OTHER
Sponsor class
Conditions
Opioid-use Disorder
Interventions
BEHAVIORAL:
Reminders messages to improve adherence.
Sponsor
Washington State University
Collaborators
[object Object]